Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
ZNTL —
ZENTALIS PHARMACEUTICALS INC
CUSIP: 98943L107 · Held by 2 superinvestors · Combined value: $6,544,800
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.0% | $3,893,056 | 2,883,745 | ADD | +558,390 |
| 2 | Ken Griffin | 0.0% | $2,651,744 | 1,964,255 | REDUCE | -146,035 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +558,390 | +24.0% |
| Ken Griffin | REDUCE | -146,035 | -6.9% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +795,802 | +52.0% |
| Ken Griffin | ADD | +1,625,950 | +335.7% |
Who Owns ZNTL? Superinvestor Holdings
ZENTALIS PHARMACEUTICALS INC is held by 2 tracked superinvestors, with a combined position value of $7 million . The largest positions are held by Jim Simons (0.0% of portfolio), Ken Griffin (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions while 1 reduced or exited.